Organizers: Li Gan, Leonard Petrucelli, Morgan H. Sheng, Marco Prinz, Jonathan Kipnis and Irene Knuesel
Progress made in human genetics has revealed increasingly more disease-associated genes for Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. These discoveries have linked neurodegenerative diseases with several common key biological processes that now need further study. At the same time, tremendous strides have been made in microglial research, revealing unexpected results that challenge the traditional view of microglia as simply scavengers of the diseased CNS. The aims to conferences on "Advances in Neurodegenerative Disease Research and Therapy" and "New Frontiers in Neuroinflammation" were to:
Keystone Symposia convenes dynamic, open, peer-reviewed conferences on the exciting new frontiers of life science. Whether you are a geneticist, an immunologist or virtually any other type of life science investigator, and whether you are from academia, industry or the government/nonprofit sector, we think you will find the experience of attending a Keystone Symposia meeting valuable and memorable.
Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 45-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.